Research Early-Stage HIV Broadly Neutralizing Antibody Susceptibility Assays Funding News Edition: April 06, 2022 NIAID supports Biodefense and Emerging Infectious Diseases Research Infrastructure as a…IRac AfricaApril 18, 2022
NIH and Tribal Nations—Commitment and Collaboration Funding News Edition: April 06, 2022 NIH is committed to upholding Tribal sovereignty, a transparent and…IRac AfricaApril 18, 2022
World TB Day 2022—Invest to End TB. Save Lives March 24, 2022 Statement of Lakshmi Ramachandra, Ph.D., Peter Kim, M.D., and Anthony S. Fauci,…IRac AfricaApril 18, 2022
NIH Experts Discuss Controlling COVID-19 in Commentary on Herd Immunity March 31, 2022 Achieving classical herd immunity against SARS-CoV-2, the virus that causes COVID-19, may…IRac AfricaApril 18, 2022
NIH Begins Clinical Trial Evaluating Second COVID-19 Booster Shots in Adults Study Includes Multiple Variant Vaccines March 31, 2022 Adults interested in joining this study should…IRac AfricaApril 18, 2022
NIH Funds New Tuberculosis Research Advancement Centers April 6, 2022 The National Institute of Allergy and Infectious Diseases (NIAID), part of the…IRac AfricaApril 18, 2022